Descarga la app Emergencing

Use of Activated Carbon Hemoperfusion and Hemodialysis in the Treatment of a Meloxicam Overdose in a Dog

Revista

Emergencing

Fecha de publicación

28 de noviembre de 2025

J Vet Emerg Crit Care (San Antonio). 2025 Nov 28. doi: 10.1111/vec.70062. Online ahead of print.

OBJECTIVE: To describe the use of activated carbon hemoperfusion (HP) and hemodialysis (HD) to treat a meloxicam overdose in a dog.

CASE SUMMARY: A 2-year-old neutered male Basset Hound mix was presented for an accidental overdose of meloxicam of up to 5.5 mg/kg. The dog was asymptomatic on presentation with mild azotemia. In-series activated carbon HP and HD were performed. Fifteen blood volumes were processed over 207 min, resulting in an 87.5% decrease in the serum meloxicam concentration, with the greatest reduction occurring within the first hour of treatment. The dog developed self-limiting hematochezia but otherwise had no clinical concerns. Eight weeks after HP/HD treatment, follow-up bloodwork showed a relatively static, mild azotemia.

NEW OR UNIQUE INFORMATION: This is the first clinical report to describe the successful use of activated carbon HP and HD in veterinary medicine and the first to document the use of HP to treat meloxicam toxicosis.

PubMed:41313643 | DOI:10.1111/vec.70062

Descarga la app Emergencing!

Accede a los abstracts en español de las revistas científicas más importantes en medicina de urgencias, emergencias y paciente crítico.

Descargo de responsabilidad
El idioma original es este artículo es el inglés. Mediante el sistema de traducción automático de la IA de emergencing, el contenido se ha traducido al español. Esta es una traducción no supervisada por lo que puede que alguna parte del contenido no refleje con exactitud la publicación original del autor/autores.